470 Targeting Pan-Tumor Associated Antigen B7H3 via Combination of Tri-specific Killer Engager and Off-the-shelf NK Cell Therapy Enhances Specificity and Function Against a Broad Range of Solid Tumors

• Joshua Walker,
• Nicholas Zorko,
• Behiye Kodal,
• Alexander Lenvik,
• Todd Lenvik,
• Daniel Vallera,
• Alejandro Garcia,
• Martin Felices

Affiliations

Joshua Walker

1University of Minnesota, Minneapolis, MN, USA

Nicholas Zorko

1University of Minnesota, Minneapolis, MN, USA

Behiye Kodal

1University of Minnesota, Minneapolis, MN, USA

Alexander Lenvik

1University of Minnesota, Minneapolis, MN, USA

Todd Lenvik

1University of Minnesota, Minneapolis, MN, USA

Daniel Vallera

1University of Minnesota, Minneapolis, MN, USA

Alejandro Garcia

2Fate Therapeutics, Inc., San Diego, CA, USA

Martin Felices

1University of Minnesota, Minneapolis, MN, USA